Quorum Health (QHCCQ) SC 13D/AQuorum Health / Mudrick Capital Management ownership change

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 1)¹

Quorum Health Corporation

(Name of Issuer)

Common Stock, par value $0.0001

(Title of Class of Securities)

74909E106

(CUSIP Number)

STEVE WOLOSKY, ESQ.

OLSHAN FROME WOLOSKY LLP

1325 Avenue of the Americas

New York, New York 10019

(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

April 8, 2020

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box¨.

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,see theNotes).

The following constitutes Amendment No. 1 to the Schedule 13D filed by the undersigned (“Amendment No. 1”). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein.

Item 3 is hereby amended and restated to read as follows:

The Shares purchased by Drawdown II LP were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 1,237,424 Shares beneficially owned by Drawdown II LP is approximately $637,456, including brokerage commissions.

The Shares purchased by Global LP were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 2,115,197 Shares beneficially owned by Global LP is approximately $987,711, including brokerage commissions.

The Shares purchased by MCM on behalf of certain managed accounts were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted. The aggregate purchase price of the 1,418,971 Shares beneficially owned by MCM on behalf of certain managed accounts is approximately $647,330, including brokerage commissions.

Item 4 is hereby amended to add the following:

On April 8, 2020, the Reporting Persons’ legal counsel delivered a letter (the “Letter”) to the Office of the United States Trustee for the District of Delaware (the “Trustee”) on behalf of the Reporting Persons, requesting that the Trustee appoint an official committee of equity security holders (the “Official Equity Committee”) to assure adequate representation of the interests of all of the Issuer’s shareholders. The Letter stated the Reporting Persons’ belief that significant equity value exists for existing shareholders but that, without the appointment of an Official Equity Committee, there is no estate fiduciary to represent shareholder interests as the board of directors and management team now in control of the Issuer have abandoned those interests in favor of the Issuer’s noteholders.

The Letter further stated the Reporting Persons’ belief that the Issuer’s entry into a restructuring support agreement (the “RSA”) with certain lenders representing approximately 75% of the obligations under the Issuer’s senior notes, and the RSA’s terms of a plan for balance sheet restructuring of the Issuer (the “Plan”), would frustrate the evaluation of the Issuer’s legitimate shareholder interests. The Reporting Persons expressed further concern in the Letter that, although all general unsecured creditors of the Issuer are paid in full in cash, the Plan provides zero recovery to shareholders that do not also own senior notes and, as a result, the Plan provides that all existing equity will be wiped out and all reorganized equity provided to the Issuer’s senior noteholders.

The foregoing description of the Letter does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter, which is filed as Exhibit 99.1, and is incorporated herein by reference.

On April 9, 2020, Mudrick Capital Management, L.P. (“Mudrick”) submitted a preliminary objection to certain first day motions (the “Preliminary Objection”) in the United States Bankruptcy Court for the District of Delaware (the “Court”). In the Preliminary Objection, Mudrick stated its concern that the Plan provides zero recovery to shareholders of the Issuer that do not also own senior notes, and requested that the Court reject as unnecessary the expedited confirmation schedule of the Plan to provide sufficient time for the Trustee to consider the appointment of an Official Equity Committee, and for equity holders to adequately evaluate the Plan, the underlying valuation it is based upon and their treatment thereunder.

The foregoing description of the Preliminary Objection does not purport to be complete and is qualified in its entirety by reference to the full text of the Preliminary Objection, which is filed as Exhibit 99.2, and is incorporated herein by reference.

Items 5 (a) – (c) are hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each Reporting Person is based upon 32,664,536 Shares outstanding, as of April 3, 2020, which is the total number of Shares outstanding as reported in the Issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 10, 2020.

Percentage: Approximately 3.8%

Percentage: Approximately 6.5%

Percentage: Approximately 6.5%

Percentage: Approximately 3.8%

Percentage: Approximately 14.6%

Percentage: Approximately 14.6%

Percentage: Approximately 14.6%

The filing of this Schedule 13D shall not be construed as an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any of the Shares reported herein. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.

Item 7 is hereby amended to add the following exhibits:

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: April 10, 2020.

SCHEDULE A

Transactions in the Shares of the Issuer Since the filing of the Schedule 13D

MUDRICK DISTRESSED OPPORTUNITY DRAWDOWN FUND II, L.P.

MUDRICK DISTRESSED OPPORTUNITY FUND GLOBAL, L.P.

MUDRICK CAPITAL MANAGEMENT, L.P.
(through certain managed accounts)